Amy Pooler is VP, HEAD OF RESEARCH of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 195,119 shares of SGMO, which is worth approximately $87,803. The most recent transaction as insider was on May 25, 2024, when has been sold 493 shares (Common Stock) at a price of $0.6 per share, resulting in proceeds of $295. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 195K
0.61% 3M change
n/a 12M change
Total Value Held $87,803

Amy Pooler Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 25 2024
SELL
Payment of exercise price or tax liability
$295 $0.6 p/Share
493 Reduced 0.25%
195,119 Common Stock
May 24 2024
SELL
Payment of exercise price or tax liability
$421 $0.6 p/Share
702 Reduced 0.36%
195,612 Common Stock
Feb 25 2024
SELL
Payment of exercise price or tax liability
$2,778 $1.13 p/Share
2,459 Reduced 1.24%
196,314 Common Stock
Feb 24 2024
SELL
Payment of exercise price or tax liability
$2,496 $1.13 p/Share
2,209 Reduced 1.1%
198,773 Common Stock
Jan 22 2024
BUY
Grant, award, or other acquisition
-
150,000 Added 42.74%
200,982 Common Stock
Nov 25 2023
SELL
Payment of exercise price or tax liability
$186 $0.38 p/Share
490 Reduced 0.95%
50,982 Common Stock
AP

Amy Pooler

VP, HEAD OF RESEARCH
Brisbane, CA

Track Institutional and Insider Activities on SGMO

Follow SANGAMO THERAPEUTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

News

Receive news related to SANGAMO THERAPEUTICS, INC

Track Activities on SGMO